Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Non-cash Items (2020 - 2024)

Historic Non-cash Items for Bolt Biotherapeutics (BOLT) over the last 5 years, with Q4 2024 value amounting to $2.8 million.

  • Bolt Biotherapeutics' Non-cash Items rose 2323333.33% to $2.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $2.8 million, marking a year-over-year increase of 2323333.33%. This contributed to the annual value of $2.8 million for FY2024, which is 2323333.33% up from last year.
  • According to the latest figures from Q4 2024, Bolt Biotherapeutics' Non-cash Items is $2.8 million, which was up 2323333.33% from $12000.0 recorded in Q4 2023.
  • In the past 5 years, Bolt Biotherapeutics' Non-cash Items ranged from a high of $14.6 million in Q4 2022 and a low of $12000.0 during Q4 2023
  • For the 5-year period, Bolt Biotherapeutics' Non-cash Items averaged around $5.6 million, with its median value being $4.7 million (2020).
  • In the last 5 years, Bolt Biotherapeutics' Non-cash Items plummeted by 9991.78% in 2023 and then soared by 2323333.33% in 2024.
  • Bolt Biotherapeutics' Non-cash Items (Quarter) stood at $4.7 million in 2020, then rose by 28.68% to $6.1 million in 2021, then soared by 140.33% to $14.6 million in 2022, then tumbled by 99.92% to $12000.0 in 2023, then surged by 23233.33% to $2.8 million in 2024.
  • Its Non-cash Items stands at $2.8 million for Q4 2024, versus $12000.0 for Q4 2023 and $14.6 million for Q4 2022.